IL18 and neoplasm: Using the MC38 mouse tumor model, we screened an array of IL-18 variants fused to anti-mPD-1 (RMP1-14) and identified an optimal IL-18 variant which, relative to wild type mouse IL-18, is ~10,000-fold attenuated and therefore named RMP-IL-18mutE4.